FDA Approved: AMMONIA N-13 — Supplemental Application (Precision Nuclear LLC)

View source ↗

Summary

The FDA approved a supplemental application for Ammonia N-13 submitted by Precision Nuclear LLC, updating the use/labeling of this radiopharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• AMMONIA N 13 (NH3N13)

Snippet

SUPPL AP for AMMONIA N-13 (AMMONIA N-13)